Go Pro

CVRx (CVRX) Competitors

CVRx logo
$2.37 -0.02 (-0.84%)
As of 04:00 PM Eastern

CVRX vs. KIDS, VREX, OFIX, NPCE, and SI

Should you buy CVRx stock or one of its competitors? CVRx's main competitors and comparable companies include OrthoPediatrics (KIDS), Varex Imaging (VREX), Orthofix Medical (OFIX), NeuroPace (NPCE), and Shoulder Innovations (SI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does CVRx compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

OrthoPediatrics presently has a consensus price target of $25.89, indicating a potential upside of 11.21%. CVRx has a consensus price target of $6.90, indicating a potential upside of 191.14%. Given CVRx's higher probable upside, analysts plainly believe CVRx is more favorable than OrthoPediatrics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics
1 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.73
CVRx
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 32.5% of OrthoPediatrics shares are owned by insiders. Comparatively, 16.6% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

OrthoPediatrics has higher revenue and earnings than CVRx. OrthoPediatrics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OrthoPediatrics$236.35M2.57-$39.65M-$1.68N/A
CVRx$56.65M1.11-$53.31M-$1.98N/A

OrthoPediatrics has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, CVRx has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

In the previous week, CVRx had 9 more articles in the media than OrthoPediatrics. MarketBeat recorded 22 mentions for CVRx and 13 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.29 beat CVRx's score of -0.40 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OrthoPediatrics
2 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
CVRx
1 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral

OrthoPediatrics has a net margin of -15.72% compared to CVRx's net margin of -84.93%. OrthoPediatrics' return on equity of -8.10% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
OrthoPediatrics-15.72% -8.10% -5.54%
CVRx -84.93%-152.35%-50.93%

Summary

OrthoPediatrics beats CVRx on 12 of the 17 factors compared between the two stocks.

How does CVRx compare to Varex Imaging?

Varex Imaging (NASDAQ:VREX) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

75.3% of CVRx shares are owned by institutional investors. 4.6% of Varex Imaging shares are owned by company insiders. Comparatively, 16.6% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, CVRx had 1 more articles in the media than Varex Imaging. MarketBeat recorded 22 mentions for CVRx and 21 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.57 beat CVRx's score of -0.40 indicating that Varex Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Varex Imaging
11 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CVRx
1 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral

Varex Imaging has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, CVRx has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

Varex Imaging currently has a consensus target price of $16.88, indicating a potential downside of 8.59%. CVRx has a consensus target price of $6.90, indicating a potential upside of 191.14%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varex Imaging
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83
CVRx
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33

Varex Imaging has a net margin of -9.64% compared to CVRx's net margin of -84.93%. Varex Imaging's return on equity of 8.19% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
Varex Imaging-9.64% 8.19% 3.63%
CVRx -84.93%-152.35%-50.93%

CVRx has lower revenue, but higher earnings than Varex Imaging. Varex Imaging is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varex Imaging$844.60M0.92-$70.30M-$2.00N/A
CVRx$56.65M1.11-$53.31M-$1.98N/A

Summary

CVRx beats Varex Imaging on 11 of the 17 factors compared between the two stocks.

How does CVRx compare to Orthofix Medical?

CVRx (NASDAQ:CVRX) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.

Orthofix Medical has a net margin of -7.41% compared to CVRx's net margin of -84.93%. Orthofix Medical's return on equity of -14.05% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-84.93% -152.35% -50.93%
Orthofix Medical -7.41%-14.05%-7.17%

CVRx has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

CVRx has higher earnings, but lower revenue than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$56.65M1.11-$53.31M-$1.98N/A
Orthofix Medical$822.31M0.50-$92.19M-$1.54N/A

CVRx currently has a consensus price target of $6.90, indicating a potential upside of 191.14%. Orthofix Medical has a consensus price target of $14.75, indicating a potential upside of 43.76%. Given CVRx's higher possible upside, equities analysts clearly believe CVRx is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

75.3% of CVRx shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, CVRx had 12 more articles in the media than Orthofix Medical. MarketBeat recorded 22 mentions for CVRx and 10 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.37 beat CVRx's score of -0.40 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
1 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Orthofix Medical beats CVRx on 9 of the 17 factors compared between the two stocks.

How does CVRx compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

NeuroPace has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market. Comparatively, CVRx has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

In the previous week, CVRx had 19 more articles in the media than NeuroPace. MarketBeat recorded 22 mentions for CVRx and 3 mentions for NeuroPace. NeuroPace's average media sentiment score of 0.34 beat CVRx's score of -0.40 indicating that NeuroPace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeuroPace
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CVRx
1 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral

NeuroPace has higher revenue and earnings than CVRx. NeuroPace is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroPace$99.99M5.07-$21.47M-$0.65N/A
CVRx$56.65M1.11-$53.31M-$1.98N/A

NeuroPace presently has a consensus target price of $19.29, indicating a potential upside of 29.61%. CVRx has a consensus target price of $6.90, indicating a potential upside of 191.14%. Given CVRx's higher probable upside, analysts plainly believe CVRx is more favorable than NeuroPace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroPace
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.80
CVRx
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33

NeuroPace has a net margin of -21.67% compared to CVRx's net margin of -84.93%. NeuroPace's return on equity of -108.20% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroPace-21.67% -108.20% -18.50%
CVRx -84.93%-152.35%-50.93%

78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 19.2% of NeuroPace shares are owned by company insiders. Comparatively, 16.6% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

NeuroPace beats CVRx on 14 of the 17 factors compared between the two stocks.

How does CVRx compare to Shoulder Innovations?

CVRx (NASDAQ:CVRX) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

75.3% of CVRx shares are owned by institutional investors. 16.6% of CVRx shares are owned by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Shoulder Innovations has lower revenue, but higher earnings than CVRx. Shoulder Innovations is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$56.65M1.11-$53.31M-$1.98N/A
Shoulder Innovations$47.32M9.24-$40.36M-$1.92N/A

CVRx currently has a consensus price target of $6.90, suggesting a potential upside of 191.14%. Shoulder Innovations has a consensus price target of $23.50, suggesting a potential upside of 11.96%. Given CVRx's higher probable upside, equities research analysts clearly believe CVRx is more favorable than Shoulder Innovations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33
Shoulder Innovations
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.63

In the previous week, Shoulder Innovations had 4 more articles in the media than CVRx. MarketBeat recorded 26 mentions for Shoulder Innovations and 22 mentions for CVRx. Shoulder Innovations' average media sentiment score of 0.29 beat CVRx's score of -0.40 indicating that Shoulder Innovations is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
1 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral
Shoulder Innovations
10 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Shoulder Innovations has a net margin of -58.33% compared to CVRx's net margin of -84.93%. Shoulder Innovations' return on equity of -23.61% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-84.93% -152.35% -50.93%
Shoulder Innovations -58.33%-23.61%-19.53%

Summary

Shoulder Innovations beats CVRx on 11 of the 16 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVRX vs. The Competition

MetricCVRxHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$63.67M$5.82B$7.02B$12.98B
Dividend YieldN/A1.78%2.58%10.20%
P/E Ratio-1.2020.21210.3420.96
Price / Sales1.1161.03588.7886.31
Price / CashN/A33.5528.8937.42
Price / Book1.586.2111.276.42
Net Income-$53.31M$147.87M$3.45B$347.03M
7 Day Performance-56.91%3.40%3.56%2.48%
1 Month Performance-56.35%1.66%-0.58%-1.04%
1 Year Performance-67.27%6.26%77.52%23.22%

CVRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVRX
CVRx
2.2927 of 5 stars
$2.37
-0.8%
$6.90
+191.1%
-67.0%$63.67M$56.65MN/A160
KIDS
OrthoPediatrics
2.3088 of 5 stars
$20.88
+0.0%
$24.78
+18.7%
+20.4%$536.20M$236.35MN/A200
VREX
Varex Imaging
2.2445 of 5 stars
$12.37
+3.8%
$16.17
+30.7%
+30.9%$520.78M$844.60MN/A2,400
OFIX
Orthofix Medical
3.1032 of 5 stars
$12.20
-0.5%
$16.00
+31.1%
-17.8%$493.12M$822.31MN/A1,605
NPCE
NeuroPace
2.7175 of 5 stars
$14.14
+4.7%
$19.29
+36.4%
+65.1%$482.03M$99.99MN/A170

Related Companies and Tools


This page (NASDAQ:CVRX) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners